Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon - PubMed (original) (raw)
Case Reports
Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon
K M Kälkner et al. QJM. 1998 Jun.
Abstract
Alpha interferons have become effective palliative treatments for patients with neuroendocrine tumours such as carcinoids and endocrine pancreatic tumours. However, several reports indicate an increased incidence of both autoantibodies and autoimmune diseases in patients treated with interferon-alpha (IFN-alpha). We studied the development of antibodies against double-stranded DNA (dsDNA) and clinical signs of autoimmune disease in 214 patients with malignant carcinoids or endocrine pancreatic tumours consecutively admitted for treatment with IFN-alpha. Seventeen patients (8%) developed antibodies against dsDNA, predominantly females (12 females and 5 males). One patient had clinical and laboratory signs of polymyositis. Among the other 16 patients, three developed hypothyroidism and in six patients the anti-dsDNA autoantibodies normalized despite continuing therapy. Although a significant number of patients developed autoantibodies against dsDNA, overt autoimmune disease related to these antibodies is a rare event and many patients spontaneously normalize these titres despite continuing IFN-alpha treatment.
Similar articles
- Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.
Oberg K, Alm G, Magnusson A, Lundqvist G, Theodorsson E, Wide L, Wilander E. Oberg K, et al. J Natl Cancer Inst. 1989 Apr 5;81(7):531-5. doi: 10.1093/jnci/81.7.531. J Natl Cancer Inst. 1989. PMID: 2466128 - Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.
Rönnblom LE, Alm GV, Oberg KE. Rönnblom LE, et al. Ann Intern Med. 1991 Aug 1;115(3):178-83. doi: 10.7326/0003-4819-115-3-178. Ann Intern Med. 1991. PMID: 2058872 - Interferons in the management of neuroendocrine tumors and their possible mechanism of action.
Oberg K. Oberg K. Yale J Biol Med. 1992 Sep-Oct;65(5):519-29; discussion 531-6. Yale J Biol Med. 1992. PMID: 1340065 Free PMC article. Review. - Interferon-alpha and autoimmune thyroid disease.
Prummel MF, Laurberg P. Prummel MF, et al. Thyroid. 2003 Jun;13(6):547-51. doi: 10.1089/105072503322238809. Thyroid. 2003. PMID: 12930598 Review.
Cited by
- Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
Chou SM, Yeh HJ, Lin TM, Chang YS, Hsu HC, Shen YC, Kuo TT, Chen JH, Chen SC, Chang CC. Chou SM, et al. Front Immunol. 2022 Oct 7;13:992819. doi: 10.3389/fimmu.2022.992819. eCollection 2022. Front Immunol. 2022. PMID: 36275719 Free PMC article. - A systematic review and meta-analysis of endocrine-related adverse events associated with interferon.
Wang L, Li B, Zhao H, Wu P, Wu Q, Chen K, Mu Y. Wang L, et al. Front Endocrinol (Lausanne). 2022 Aug 5;13:949003. doi: 10.3389/fendo.2022.949003. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35992107 Free PMC article. - Interferons in Systemic Lupus Erythematosus.
Sirobhushanam S, Lazar S, Kahlenberg JM. Sirobhushanam S, et al. Rheum Dis Clin North Am. 2021 Aug;47(3):297-315. doi: 10.1016/j.rdc.2021.04.001. Epub 2021 Jun 10. Rheum Dis Clin North Am. 2021. PMID: 34215365 Free PMC article. Review. - Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies.
Ali Khan W. Ali Khan W. Cent Eur J Immunol. 2018;43(1):58-68. doi: 10.5114/ceji.2018.74874. Epub 2018 Mar 30. Cent Eur J Immunol. 2018. PMID: 29736147 Free PMC article. - Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
Murayama G, Furusawa N, Chiba A, Yamaji K, Tamura N, Miyake S. Murayama G, et al. Arthritis Res Ther. 2017 Oct 19;19(1):234. doi: 10.1186/s13075-017-1441-7. Arthritis Res Ther. 2017. PMID: 29052537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical